PMC:7795856 / 283-780
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
19 | 365-368 | Gene | denotes | Tα1 | Gene:134864 |
21 | 372-388 | Species | denotes | Escherichia coli | Tax:562 |
25 | 307-308 | Chemical | denotes | N | MESH:D009584 |
26 | 324-328 | Chemical | denotes | RimJ | |
32 | 44-52 | Disease | denotes | COVID-19 | MESH:C000657245 |
33 | 53-63 | Disease | denotes | infections | MESH:D007239 |
34 | 68-74 | Disease | denotes | cancer | MESH:D009369 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T4 | 68-74 | Phenotype | denotes | cancer | http://purl.obolibrary.org/obo/HP_0002664 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5 | 76-239 | Sentence | denotes | Manufacturing of this N-terminally acetylated 28-residue peptide is demanding, and its short plasma half-life limits in vivo efficacy and requires frequent dosing. |
T6 | 240-403 | Sentence | denotes | Here, we combined the PASylation technology with enzymatic in situ N-acetylation by RimJ to produce a long-acting version of Tα1 in Escherichia coli at high yield. |